| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.689 | 0.007 | 0.689 | Spasmolytic | 0.621 0.011 DBMET02635 0.506 0.022 DBMET02636 | ||
| 0.623 | 0.004 | 0.623 | Antihistaminic | 0.529 0.004 DBMET02635 0.325 0.009 DBMET02636 | ||
| 0.62 | 0.003 | 0.62 | Histamine H1 receptor antagonist | 0.457 0.004 DBMET02635 0.329 0.005 DBMET02636 | ||
| 0.62 | 0.004 | 0.62 | Histamine antagonist | 0.525 0.004 DBMET02635 0.318 0.009 DBMET02636 | ||
| 0.599 | 0.007 | 0.599 | Potassium channel (Voltage-sensitive) blocker | 0.482 0.016 DBMET02635 0.432 0.022 DBMET02636 | ||
| 0.593 | 0.009 | 0.593 | HERG channel blocker | 0.436 0.022 DBMET02635 0.402 0.028 DBMET02636 | ||
| 0.58 | 0.009 | 0.58 | Cardiotonic | 0.499 0.015 DBMET02635 0.483 0.017 DBMET02636 | ||
| 0.494 | 0.002 | 0.494 | Histamine N-methyltransferase inhibitor | 0.346 0.003 DBMET02635 0.42 0.002 DBMET02636 | ||
| 0.492 | 0.004 | 0.492 | Nav1.3 sodium channel blocker | 0.487 0.004 DBMET02635 0.325 0.007 DBMET02636 | ||
| 0.487 | 0.012 | 0.487 | Potassium channel blocker | 0.357 0.031 DBMET02635 0.281 0.053 DBMET02636 | ||
| 0.485 | 0.011 | 0.485 | Sigma receptor agonist | 0.418 0.019 DBMET02635 0.335 0.033 DBMET02636 | ||
| 0.45 | 0.005 | 0.45 | Cholinergic antagonist | 0.379 0.009 DBMET02635 0.316 0.013 DBMET02636 | ||
| 0.446 | 0.003 | 0.446 | Acetylcholine M4 receptor antagonist | 0.262 0.004 DBMET02635 0.204 0.006 DBMET02636 | ||
| 0.442 | 0.006 | 0.442 | Acetylcholine antagonist | 0.369 0.009 DBMET02635 0.312 0.013 DBMET02636 | ||
| 0.42 | 0.005 | 0.42 | Acetylcholine M1 receptor antagonist | 0.356 0.008 DBMET02635 0.355 0.008 DBMET02636 | ||
| 0.412 | 0.005 | 0.412 | Ca(v)3.3 blocker | 0.38 0.007 DBMET02635 0.369 0.009 DBMET02636 | ||
| 0.408 | 0.033 | 0.408 | Vasodilator, coronary | 0.372 0.046 DBMET02635 0.318 0.074 DBMET02636 | ||
| 0.372 | 0.005 | 0.372 | Acetylcholine muscarinic antagonist | 0.287 0.01 DBMET02635 0.251 0.014 DBMET02636 | ||
| 0.369 | 0.003 | 0.469 | Histamine agonist | 0.469 0.002 DBMET02635 0.419 0.002 DBMET02636 | DBMET02635 | |
| 0.4 | 0.055 | 0.4 | Vasodilator, peripheral | 0.299 0.097 DBMET02635 0.19 0.188 DBMET02636 | ||
| 0.345 | 0.007 | 0.346 | Alpha 2b adrenoreceptor antagonist | 0.346 0.006 DBMET02635 0.201 0.023 DBMET02636 | DBMET02635 | |
| 0.352 | 0.031 | 0.378 | Psychostimulant | 0.378 0.026 DBMET02635 0.284 0.047 DBMET02636 | DBMET02635 | |
| 0.319 | 0.003 | 0.387 | Histamine H2 receptor antagonist | 0.387 0.003 DBMET02635 0.236 0.004 DBMET02636 | DBMET02635 | |
| 0.36 | 0.06 | 0.36 | Cholesterol antagonist | 0.31 0.085 DBMET02635 0.311 0.084 DBMET02636 | ||
| 0.366 | 0.092 | 0.366 | Histamine release inhibitor | 0.252 0.154 DBMET02635 0.339 0.105 DBMET02636 | ||
| 0.282 | 0.009 | 0.282 | Nav1.1 sodium channel blocker | 0.249 0.012 DBMET02635 0.202 0.018 DBMET02636 | ||
| 0.285 | 0.017 | 0.285 | Antipruritic | 0.285 0.017 DBMET02635 0.283 0.017 DBMET02636 | ||
| 0.289 | 0.024 | 0.298 | Neuropeptide Y2 antagonist | 0.268 0.04 DBMET02635 0.298 0.02 DBMET02636 | DBMET02636 | |
| 0.296 | 0.032 | 0.308 | 5 Hydroxytryptamine 1E antagonist | 0.308 0.025 DBMET02635 0.26 0.064 DBMET02636 | DBMET02635 | |
| 0.271 | 0.008 | 0.271 | Nav1.6 sodium channel blocker | 0.222 0.014 DBMET02635 0.207 0.017 DBMET02636 | ||
| 0.294 | 0.034 | 0.294 | Anesthetic general | 0.211 0.069 DBMET02635 0.231 0.059 DBMET02636 | ||
| 0.258 | 0.005 | 0.258 | Acetylcholine M2 receptor antagonist | 0.17 0.009 DBMET02635 0.144 0.012 DBMET02636 | ||
| 0.374 | 0.125 | 0.461 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.461 0.054 DBMET02635 0.373 0.126 DBMET02636 | DBMET02635 | |
| 0.25 | 0.004 | 0.25 | Acetylcholine M5 receptor antagonist | 0.191 0.005 DBMET02635 0.131 0.01 DBMET02636 | ||
| 0.319 | 0.074 | 0.416 | Calcium channel activator | 0.416 0.019 DBMET02635 0.368 0.039 DBMET02636 | DBMET02635 | |
| 0.249 | 0.005 | 0.249 | Acetylcholine M3 receptor antagonist | 0.202 0.007 DBMET02635 0.152 0.011 DBMET02636 | ||
| 0.234 | 0.005 | 0.234 | Histamine H3 receptor antagonist | 0.184 0.005 DBMET02635 0.11 0.01 DBMET02636 | ||
| 0.324 | 0.1 | 0.36 | Calpain 2 inhibitor | 0.36 0.082 DBMET02635 0.298 0.115 DBMET02636 | DBMET02635 | |
| 0.224 | 0.006 | 0.224 | Sphingomyelinase inhibitor | 0.208 0.008 DBMET02635 0.152 0.023 DBMET02636 | ||
| 0.304 | 0.092 | 0.36 | Transcription factor NF kappa B inhibitor | 0.353 0.076 DBMET02635 0.36 0.074 DBMET02636 | DBMET02636 | |
| 0.227 | 0.03 | 0.229 | 5 Hydroxytryptamine 3E antagonist | 0.229 0.028 DBMET02635 0.213 0.043 DBMET02636 | DBMET02635 | |
| 0.322 | 0.125 | 0.471 | Analgesic | 0.471 0.058 DBMET02635 0.251 0.182 DBMET02636 | DBMET02635 | |
| 0.216 | 0.024 | 0.216 | Calcium channel blocker | 0.159 0.052 DBMET02635 0.113 0.095 DBMET02636 | ||
| 0.204 | 0.012 | 0.208 | Acetylcholine nicotinic antagonist | 0.208 0.012 DBMET02635 0.172 0.016 DBMET02636 | DBMET02635 | |
| 0.219 | 0.028 | 0.219 | Nav1.2 sodium channel blocker | 0.209 0.031 DBMET02635 0.19 0.038 DBMET02636 | ||
| 0.195 | 0.005 | 0.207 | Acetylcholine release stimulant | 0.207 0.004 DBMET02635 0.162 0.011 DBMET02636 | DBMET02635 | |
| 0.218 | 0.028 | 0.218 | Anesthetic local | 0.159 0.045 DBMET02635 | ||
| 0.326 | 0.138 | 0.449 | 5 Hydroxytryptamine release inhibitor | 0.331 0.133 DBMET02635 0.449 0.052 DBMET02636 | DBMET02636 | |
| 0.198 | 0.017 | 0.198 | Ca(v)2.2 blocker | 0.164 0.025 DBMET02635 0.134 0.034 DBMET02636 | ||
| 0.246 | 0.065 | 0.246 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.197 | 0.02 | 0.222 | Neuropeptide Y1 antagonist | 0.206 0.016 DBMET02635 0.222 0.013 DBMET02636 | DBMET02636 | |
| 0.194 | 0.018 | 0.194 | 5 Hydroxytryptamine 2C antagonist | 0.17 0.022 DBMET02635 0.112 0.039 DBMET02636 | ||
| 0.244 | 0.072 | 0.244 | Vasodilator | 0.202 0.103 DBMET02635 0.16 0.143 DBMET02636 | ||
| 0.291 | 0.122 | 0.343 | GABA C receptor rho-3 antagonist | 0.31 0.109 DBMET02635 0.343 0.089 DBMET02636 | DBMET02636 | |
| 0.166 | 0.002 | 0.208 | Histamine H2 receptor agonist | 0.208 0.001 DBMET02635 0.182 0.001 DBMET02636 | DBMET02635 | |
| 0.171 | 0.008 | 0.223 | Myeloperoxidase inhibitor | 0.187 0.006 DBMET02635 0.223 0.004 DBMET02636 | DBMET02636 | |
| 0.176 | 0.017 | 0.208 | Neuropeptide Y antagonist | 0.16 0.02 DBMET02635 0.208 0.014 DBMET02636 | DBMET02636 | |
| 0.18 | 0.022 | 0.18 | Calcium channel (voltage-sensitive) blocker | 0.142 0.038 DBMET02635 0.103 0.079 DBMET02636 | ||
| 0.178 | 0.021 | 0.178 | Alpha 2 adrenoreceptor antagonist | 0.172 0.022 DBMET02635 0.098 0.049 DBMET02636 | ||
| 0.162 | 0.008 | 0.296 | Adrenaline uptake inhibitor | 0.296 0.004 DBMET02635 0.094 0.02 DBMET02636 | DBMET02635 | |
| 0.169 | 0.018 | 0.169 | Calcium antagonist | 0.078 0.066 DBMET02635 | ||
| 0.162 | 0.014 | 0.224 | CYP2A6 inhibitor | 0.175 0.011 DBMET02635 0.224 0.005 DBMET02636 | DBMET02636 | |
| 0.156 | 0.009 | 0.156 | Calcium channel L-type blocker | 0.113 0.018 DBMET02635 0.082 0.038 DBMET02636 | ||
| 0.232 | 0.09 | 0.232 | Aldehyde oxidase inhibitor | |||
| 0.16 | 0.02 | 0.16 | Alpha 2a adrenoreceptor antagonist | 0.155 0.021 DBMET02635 0.088 0.043 DBMET02636 | ||
| 0.166 | 0.029 | 0.166 | Calcium channel N-type blocker | 0.152 0.036 DBMET02635 0.108 0.082 DBMET02636 | ||
| 0.151 | 0.016 | 0.266 | 5 Hydroxytryptamine uptake inhibitor | 0.266 0.008 DBMET02635 | DBMET02635 | |
| 0.134 | 0.001 | 0.196 | Histamine H1 receptor agonist | 0.196 0.001 DBMET02635 0.153 0.001 DBMET02636 | DBMET02635 | |
| 0.139 | 0.012 | 0.139 | Alpha 2d adrenoreceptor antagonist | 0.133 0.015 DBMET02635 0.135 0.014 DBMET02636 | ||
| 0.15 | 0.027 | 0.15 | Gastric antisecretory | 0.148 0.028 DBMET02635 | ||
| 0.137 | 0.017 | 0.164 | Lanosterol 14 alpha demethylase inhibitor | 0.126 0.025 DBMET02635 0.164 0.008 DBMET02636 | DBMET02636 | |
| 0.304 | 0.189 | 0.304 | Caspase 9 stimulant | 0.282 0.214 DBMET02636 | ||
| 0.162 | 0.049 | 0.191 | Sodium channel blocker | 0.191 0.036 DBMET02635 0.179 0.041 DBMET02636 | DBMET02635 | |
| 0.13 | 0.018 | 0.134 | HIV-1 reverse transcriptase inhibitor | 0.118 0.023 DBMET02635 0.134 0.018 DBMET02636 | DBMET02636 | |
| 0.158 | 0.046 | 0.244 | Glutamate receptor antagonist | 0.153 0.049 DBMET02635 0.244 0.016 DBMET02636 | DBMET02636 | |
| 0.152 | 0.044 | 0.152 | 5 Hydroxytryptamine 2 antagonist | 0.134 0.051 DBMET02635 | ||
| 0.166 | 0.059 | 0.225 | Insulin secretagoues | 0.195 0.039 DBMET02635 0.225 0.026 DBMET02636 | DBMET02636 | |
| 0.135 | 0.032 | 0.135 | 5 Hydroxytryptamine 2A antagonist | 0.112 0.041 DBMET02635 | ||
| 0.191 | 0.09 | 0.191 | Anticonvulsant | 0.157 0.12 DBMET02635 0.175 0.103 DBMET02636 | ||
| 0.136 | 0.036 | 0.136 | Mediator release inhibitor | 0.119 0.048 DBMET02635 0.13 0.039 DBMET02636 | ||
| 0.126 | 0.026 | 0.312 | Porphobilinogen synthase inhibitor | 0.094 0.039 DBMET02635 0.312 0.005 DBMET02636 | DBMET02636 | |
| 0.115 | 0.015 | 0.115 | Dopamine uptake inhibitor | 0.106 0.017 DBMET02635 0.059 0.039 DBMET02636 | ||
| 0.139 | 0.04 | 0.139 | Chelator | 0.133 0.044 DBMET02635 0.121 0.053 DBMET02636 | ||
| 0.206 | 0.108 | 0.242 | Calpain inhibitor | 0.242 0.073 DBMET02635 0.242 0.073 DBMET02636 | DBMET02636 | |
| 0.11 | 0.017 | 0.11 | MAP kinase kinase 10 inhibitor | 0.08 0.029 DBMET02635 0.074 0.035 DBMET02636 | ||
| 0.134 | 0.042 | 0.134 | Alpha adrenoreceptor antagonist | 0.127 0.044 DBMET02635 | ||
| 0.117 | 0.025 | 0.117 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.219 | 0.13 | 0.256 | Insulysin inhibitor | 0.239 0.107 DBMET02635 0.256 0.091 DBMET02636 | DBMET02636 | |
| 0.145 | 0.058 | 0.18 | Sodium channel (voltage-gated) blocker | 0.18 0.038 DBMET02635 0.173 0.041 DBMET02636 | DBMET02635 | |
| 0.148 | 0.066 | 0.163 | Adenylate cyclase stimulant | 0.163 0.044 DBMET02635 0.16 0.048 DBMET02636 | DBMET02635 | |
| 0.084 | 0.004 | 0.086 | Geranyltranstransferase inhibitor | 0.072 0.007 DBMET02635 0.086 0.004 DBMET02636 | DBMET02636 | |
| 0.126 | 0.047 | 0.143 | Nav1.5 sodium channel blocker | 0.143 0.032 DBMET02635 0.138 0.035 DBMET02636 | DBMET02635 | |
| 0.096 | 0.017 | 0.11 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.091 0.021 DBMET02635 0.11 0.008 DBMET02636 | DBMET02636 | |
| 0.151 | 0.077 | 0.184 | Diuretic | 0.149 0.078 DBMET02635 0.184 0.051 DBMET02636 | DBMET02636 | |
| 0.142 | 0.069 | 0.147 | Heat shock protein 70 antagonist | 0.147 0.054 DBMET02636 | DBMET02636 | |
| 0.1 | 0.028 | 0.172 | Alpha adrenoreceptor agonist | 0.172 0.012 DBMET02635 0.106 0.025 DBMET02636 | DBMET02635 | |
| 0.114 | 0.043 | 0.114 | Prolactin inhibitor | |||
| 0.088 | 0.019 | 0.132 | Alpha 2 adrenoreceptor agonist | 0.132 0.008 DBMET02635 0.102 0.014 DBMET02636 | DBMET02635 | |
| 0.103 | 0.036 | 0.103 | 5 Hydroxytryptamine 1 antagonist | 0.075 0.05 DBMET02635 | ||
| 0.12 | 0.053 | 0.19 | GABA C receptor antagonist | 0.11 0.063 DBMET02635 0.19 0.015 DBMET02636 | DBMET02636 | |
| 0.094 | 0.029 | 0.094 | CC chemokine 5 receptor agonist | 0.08 0.064 DBMET02635 0.079 0.07 DBMET02636 | ||
| 0.1 | 0.035 | 0.1 | Vanilloid antagonist | 0.08 0.047 DBMET02635 | ||
| 0.082 | 0.018 | 0.082 | Phosphodiesterase 1C inhibitor | |||
| 0.1 | 0.036 | 0.12 | Hematopoietic | 0.099 0.037 DBMET02635 0.12 0.022 DBMET02636 | DBMET02636 | |
| 0.084 | 0.021 | 0.084 | 5 Hydroxytryptamine 5A antagonist | 0.066 0.035 DBMET02635 | ||
| 0.124 | 0.062 | 0.124 | 5 Hydroxytryptamine antagonist | 0.099 0.079 DBMET02635 | ||
| 0.097 | 0.036 | 0.111 | Alpha 1b adrenoreceptor antagonist | 0.111 0.032 DBMET02635 | DBMET02635 | |
| 0.073 | 0.012 | 0.114 | Histone deacetylase 7 inhibitor | 0.114 0.007 DBMET02635 0.04 0.023 DBMET02636 | DBMET02635 | |
| 0.17 | 0.11 | 0.192 | Neurotrophic factor enhancer | 0.192 0.085 DBMET02635 0.188 0.089 DBMET02636 | DBMET02635 | |
| 0.083 | 0.024 | 0.086 | Glutamate (mGluR7) antagonist | 0.065 0.053 DBMET02635 0.086 0.021 DBMET02636 | DBMET02636 | |
| 0.114 | 0.054 | 0.114 | Alpha 2c adrenoreceptor antagonist | 0.111 0.056 DBMET02635 | ||
| 0.075 | 0.016 | 0.126 | Aconitate hydratase inhibitor | 0.068 0.02 DBMET02635 0.126 0.005 DBMET02636 | DBMET02636 | |
| 0.203 | 0.145 | 0.27 | 5 Hydroxytryptamine uptake stimulant | 0.207 0.139 DBMET02635 0.27 0.063 DBMET02636 | DBMET02636 | |
| 0.094 | 0.037 | 0.121 | Nicotinic alpha4beta2 receptor antagonist | 0.12 0.018 DBMET02635 0.121 0.017 DBMET02636 | DBMET02636 | |
| 0.078 | 0.022 | 0.078 | 5 Hydroxytryptamine 5 antagonist | 0.062 0.034 DBMET02635 | ||
| 0.153 | 0.097 | 0.153 | ATPase inhibitor | 0.144 0.111 DBMET02635 | ||
| 0.102 | 0.047 | 0.249 | Toll-Like receptor 3 antagonist | 0.249 0.004 DBMET02635 0.155 0.013 DBMET02636 | DBMET02635 | |
| 0.08 | 0.025 | 0.08 | Potassium channel Kv1.5 blocker | 0.076 0.027 DBMET02635 0.068 0.031 DBMET02636 | ||
| 0.095 | 0.041 | 0.158 | Adrenaline agonist | 0.158 0.013 DBMET02635 0.1 0.037 DBMET02636 | DBMET02635 | |
| 0.115 | 0.061 | 0.115 | DNA intercalator | |||
| 0.091 | 0.039 | 0.091 | Estrogen-related receptor beta agonist | |||
| 0.096 | 0.045 | 0.096 | Alpha 1 adrenoreceptor antagonist | 0.09 0.048 DBMET02635 | ||
| 0.093 | 0.043 | 0.108 | Acetylcholine nicotinic agonist | 0.108 0.032 DBMET02635 | DBMET02635 | |
| 0.13 | 0.08 | 0.13 | Neurotrophic factor | |||
| 0.072 | 0.022 | 0.072 | Phosphodiesterase 1A inhibitor | |||
| 0.185 | 0.135 | 0.458 | Superoxide dismutase inhibitor | 0.216 0.101 DBMET02635 0.458 0.018 DBMET02636 | DBMET02636 | |
| 0.083 | 0.034 | 0.091 | Neuronal nicotinic receptor antagonist | 0.091 0.029 DBMET02635 0.079 0.037 DBMET02636 | DBMET02635 | |
| 0.082 | 0.033 | 0.101 | Fibroblast growth factor 2 antagonist | 0.101 0.024 DBMET02635 0.071 0.041 DBMET02636 | DBMET02635 | |
| 0.079 | 0.031 | 0.079 | Protein kinase C beta inhibitor | 0.064 0.06 DBMET02635 0.063 0.062 DBMET02636 | ||
| 0.058 | 0.013 | 0.093 | Histone deacetylase 9 inhibitor | 0.093 0.007 DBMET02635 0.04 0.025 DBMET02636 | DBMET02635 | |
| 0.081 | 0.037 | 0.082 | Leukotriene synthesis inhibitor | 0.064 0.05 DBMET02635 0.082 0.036 DBMET02636 | DBMET02636 | |
| 0.071 | 0.026 | 0.077 | Fibroblast growth factor 4 antagonist | 0.077 0.02 DBMET02635 0.065 0.032 DBMET02636 | DBMET02635 | |
| 0.142 | 0.098 | 0.142 | Arachidonic acid antagonist | |||
| 0.081 | 0.039 | 0.081 | 5 Hydroxytryptamine 1A antagonist | 0.057 0.056 DBMET02635 | ||
| 0.07 | 0.028 | 0.07 | Calcium channel T-type blocker | |||
| 0.069 | 0.027 | 0.074 | Sphingosine 1-phosphate receptor 3 antagonist | 0.073 0.023 DBMET02635 0.074 0.022 DBMET02636 | DBMET02636 | |
| 0.049 | 0.011 | 0.064 | Histamine H3 receptor agonist | 0.062 0.009 DBMET02635 0.064 0.008 DBMET02636 | DBMET02636 | |
| 0.176 | 0.139 | 0.196 | DNA damaging | 0.196 0.119 DBMET02636 | DBMET02636 | |
| 0.175 | 0.139 | 0.216 | Nitric-oxide synthase stimulant | 0.198 0.092 DBMET02635 0.216 0.065 DBMET02636 | DBMET02636 | |
| 0.178 | 0.143 | 0.361 | 5 Hydroxytryptamine release stimulant | 0.361 0.054 DBMET02635 0.353 0.056 DBMET02636 | DBMET02635 | |
| 0.174 | 0.141 | 0.245 | Hypoglycemic | 0.245 0.08 DBMET02636 | DBMET02636 | |
| 0.093 | 0.06 | 0.101 | Antiadrenergic | 0.101 0.055 DBMET02635 | DBMET02635 | |
| 0.096 | 0.063 | 0.112 | Interleukin 1 beta converting enzyme inhibitor | 0.112 0.043 DBMET02635 0.097 0.061 DBMET02636 | DBMET02635 | |
| 0.103 | 0.071 | 0.103 | Protein kinase C gamma inhibitor | |||
| 0.068 | 0.037 | 0.162 | CXC chemokine 4 receptor antagonist | 0.066 0.038 DBMET02635 0.162 0.014 DBMET02636 | DBMET02636 | |
| 0.099 | 0.068 | 0.372 | GABA C receptor agonist | 0.106 0.061 DBMET02635 0.372 0.006 DBMET02636 | DBMET02636 | |
| 0.041 | 0.011 | 0.053 | Methionyl aminopeptidase 1 inhibitor | 0.046 0.008 DBMET02635 0.053 0.005 DBMET02636 | DBMET02636 | |
| 0.053 | 0.024 | 0.073 | Dopamine beta hydroxylase inhibitor | 0.056 0.019 DBMET02635 0.073 0.007 DBMET02636 | DBMET02636 | |
| 0.105 | 0.078 | 0.105 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.063 | 0.037 | 0.07 | Beta 2 adrenoreceptor agonist | 0.07 0.019 DBMET02635 0.065 0.03 DBMET02636 | DBMET02635 | |
| 0.049 | 0.023 | 0.049 | Liver X receptor agonist | |||
| 0.033 | 0.008 | 0.036 | Alpha 2d adrenoreceptor agonist | 0.035 0.007 DBMET02635 0.036 0.007 DBMET02636 | DBMET02636 | |
| 0.044 | 0.019 | 0.057 | Diamine oxidase inhibitor | 0.049 0.015 DBMET02635 0.057 0.011 DBMET02636 | DBMET02636 | |
| 0.074 | 0.049 | 0.074 | Telomerase inhibitor | |||
| 0.078 | 0.053 | 0.083 | MAP kinase 10 inhibitor | 0.083 0.047 DBMET02635 0.074 0.058 DBMET02636 | DBMET02635 | |
| 0.094 | 0.071 | 0.126 | Bronchodilator | 0.126 0.041 DBMET02635 0.093 0.072 DBMET02636 | DBMET02635 | |
| 0.05 | 0.027 | 0.05 | Benzodiazepine antagonist | |||
| 0.084 | 0.061 | 0.084 | Acetylcholine agonist | |||
| 0.035 | 0.012 | 0.044 | Epoxide hydrolase 2 inhibitor | 0.044 0.008 DBMET02635 0.036 0.011 DBMET02636 | DBMET02635 | |
| 0.038 | 0.015 | 0.038 | 5 Hydroxytryptamine 1D agonist | 0.028 0.02 DBMET02635 | ||
| 0.234 | 0.211 | 0.234 | MAP kinase kinase 6 inhibitor | |||
| 0.058 | 0.035 | 0.058 | MAP kinase kinase 9 inhibitor | |||
| 0.187 | 0.165 | 0.226 | MAP kinase kinase 3 inhibitor | 0.191 0.151 DBMET02635 0.226 0.062 DBMET02636 | DBMET02636 | |
| 0.048 | 0.027 | 0.048 | Potassium channel small-conductance Ca-activated blocker | 0.046 0.03 DBMET02635 | ||
| 0.085 | 0.064 | 0.092 | Adrenaline antagonist | 0.092 0.059 DBMET02635 | DBMET02635 | |
| 0.056 | 0.036 | 0.056 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.055 | 0.035 | 0.055 | Nicotinic receptor alpha7 subunit antagonist | 0.05 0.044 DBMET02635 | ||
| 0.063 | 0.044 | 0.067 | 5 Hydroxytryptamine 3 agonist | 0.067 0.039 DBMET02636 | DBMET02636 | |
| 0.05 | 0.031 | 0.057 | Histamine H4 receptor antagonist | 0.054 0.025 DBMET02635 0.057 0.021 DBMET02636 | DBMET02636 | |
| 0.043 | 0.025 | 0.043 | Acetyl-CoA transferase 1 inhibitor | |||
| 0.052 | 0.034 | 0.077 | Chemokine receptor agonist | 0.05 0.035 DBMET02635 0.077 0.011 DBMET02636 | DBMET02636 | |
| 0.064 | 0.046 | 0.064 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.075 | 0.057 | 0.088 | Fibroblast growth factor 3 antagonist | 0.088 0.041 DBMET02635 0.075 0.058 DBMET02636 | DBMET02635 | |
| 0.057 | 0.039 | 0.057 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.08 | 0.064 | 0.08 | GABA A receptor agonist | 0.076 0.071 DBMET02635 | ||
| 0.03 | 0.015 | 0.03 | Urotensin II agonist | |||
| 0.058 | 0.042 | 0.061 | Alpha 1d adrenoreceptor antagonist | 0.061 0.04 DBMET02635 | DBMET02635 | |
| 0.062 | 0.047 | 0.062 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.113 | 0.1 | 0.113 | Interleukin 1 antagonist | |||
| 0.058 | 0.046 | 0.058 | Bcl-xL inhibitor | |||
| 0.095 | 0.083 | 0.118 | Cystathionine beta-synthase inhibitor | 0.118 0.059 DBMET02636 | DBMET02636 | |
| 0.055 | 0.043 | 0.055 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.051 | 0.04 | 0.052 | Toll-Like receptor 8 antagonist | 0.052 0.039 DBMET02636 | DBMET02636 | |
| 0.022 | 0.011 | 0.022 | Apolipoprotein B inhibitor | 0.019 0.015 DBMET02635 | ||
| 0.028 | 0.017 | 0.028 | Myristoyl transferase inhibitor | 0.028 0.017 DBMET02635 0.028 0.018 DBMET02636 | ||
| 0.085 | 0.075 | 0.085 | ABCA1 expression enhancer | |||
| 0.094 | 0.084 | 0.119 | GABA receptor agonist | 0.119 0.058 DBMET02636 | DBMET02636 | |
| 0.039 | 0.029 | 0.039 | CF transmembrane conductance regulator antagonist | |||
| 0.029 | 0.019 | 0.029 | Estrogen-related receptor gamma antagonist | |||
| 0.021 | 0.011 | 0.032 | Histamine H4 receptor agonist | 0.032 0.006 DBMET02635 0.028 0.007 DBMET02636 | DBMET02635 | |
| 0.055 | 0.046 | 0.076 | Botulinum neurotoxin type A inhibitor | 0.076 0.02 DBMET02636 | DBMET02636 | |
| 0.098 | 0.089 | 0.098 | Cholesterol synthesis inhibitor | |||
| 0.065 | 0.056 | 0.072 | Exportin-1 inhibitor | 0.072 0.038 DBMET02636 | DBMET02636 | |
| 0.048 | 0.039 | 0.048 | Prolyl endopeptidase inhibitor | |||
| 0.077 | 0.069 | 0.077 | Ca(v)3.1 blocker | |||
| 0.031 | 0.023 | 0.032 | Histone deacetylase 4 inhibitor | 0.032 0.022 DBMET02635 | DBMET02635 | |
| 0.138 | 0.132 | 0.168 | Phospholipase C inhibitor | 0.168 0.075 DBMET02636 | DBMET02636 | |
| 0.027 | 0.021 | 0.041 | Nicotinic alpha4beta2 receptor agonist | 0.041 0.008 DBMET02635 | DBMET02635 | |
| 0.033 | 0.027 | 0.033 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.05 | 0.044 | 0.05 | Alpha 1L adrenoreceptor antagonist | |||
| 0.088 | 0.083 | 0.088 | Falcipain 3 inhibitor | |||
| 0.059 | 0.055 | 0.077 | Histone deacetylase inhibitor | 0.077 0.034 DBMET02635 0.059 0.056 DBMET02636 | DBMET02635 | |
| 0.098 | 0.093 | 0.098 | Photosensitizer | |||
| 0.106 | 0.103 | 0.112 | Toll-Like receptor 9 antagonist | 0.112 0.095 DBMET02635 | DBMET02635 | |
| 0.048 | 0.045 | 0.048 | Acetyl-CoA transferase inhibitor | |||
| 0.015 | 0.011 | 0.022 | CXC chemokine 4 receptor agonist | 0.022 0.005 DBMET02636 | DBMET02636 | |
| 0.018 | 0.016 | 0.026 | Alpha 2b adrenoreceptor agonist | 0.022 0.008 DBMET02635 0.026 0.005 DBMET02636 | DBMET02636 | |
| 0.061 | 0.059 | 0.065 | Protein kinase C alpha inhibitor | 0.065 0.052 DBMET02636 | DBMET02636 | |
| 0.027 | 0.026 | 0.027 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.065 | 0.065 | 0.073 | Na+ K+ transporting ATPase inhibitor | 0.073 0.057 DBMET02636 | DBMET02636 | |
| 0.102 | 0.102 | 0.153 | Transcription factor STAT6 inhibitor | 0.102 0.1 DBMET02635 0.153 0.021 DBMET02636 | DBMET02636 | |
| 0.121 | 0.123 | 0.162 | GABA C receptor rho-2 antagonist | 0.162 0.059 DBMET02635 0.127 0.112 DBMET02636 | DBMET02635 | |
| 0.063 | 0.065 | 0.066 | Secretase beta inhibitor | 0.065 0.059 DBMET02635 0.066 0.056 DBMET02636 | DBMET02636 | |
| 0.023 | 0.027 | 0.045 | AMPA 3 receptor antagonist | 0.045 0.011 DBMET02636 | DBMET02636 | |
| 0.043 | 0.047 | 0.061 | Beta 2 adrenoreceptor antagonist | 0.061 0.023 DBMET02635 | DBMET02635 | |
| 0.056 | 0.06 | 0.062 | Heme oxygenase stimulant | 0.062 0.04 DBMET02635 | DBMET02635 | |
| 0.12 | 0.125 | 0.133 | Sphingosine 1-phosphate receptor 5 antagonist | 0.133 0.094 DBMET02636 | DBMET02636 | |
| 0.032 | 0.037 | 0.046 | Glutamate (mGluR8) antagonist | 0.046 0.011 DBMET02636 | DBMET02636 | |
| 0.046 | 0.052 | 0.055 | 5 Hydroxytryptamine 1B agonist | 0.055 0.033 DBMET02635 | DBMET02635 | |
| 0.054 | 0.061 | 0.078 | Corticotropin releasing factor 2 receptor antagonist | 0.078 0.019 DBMET02636 | DBMET02636 | |
| 0.042 | 0.049 | 0.048 | Beta adrenoreceptor agonist | 0.048 0.022 DBMET02635 | DBMET02635 | |
| 0.005 | 0.013 | 0.014 | Integrin alphaVbeta5 antagonist | 0.009 0.008 DBMET02635 0.014 0.005 DBMET02636 | DBMET02636 | |
| 0.035 | 0.044 | 0.039 | Plasmepsin II inhibitor | 0.039 0.032 DBMET02636 | DBMET02636 | |
| 0.055 | 0.064 | 0.073 | Beta adrenoreceptor antagonist | 0.073 0.035 DBMET02635 | DBMET02635 | |
| 0.015 | 0.024 | 0.027 | Vitronectin receptor antagonist | 0.02 0.015 DBMET02635 0.027 0.011 DBMET02636 | DBMET02636 | |
| 0.021 | 0.031 | 0.028 | Calcium-sensing receptor agonist | 0.028 0.016 DBMET02636 | DBMET02636 | |
| 0.036 | 0.05 | 0.045 | Glutamate (mGluR group I) agonist | 0.044 0.038 DBMET02635 0.045 0.037 DBMET02636 | DBMET02636 | |
| 0.013 | 0.028 | 0.026 | Alpha 2c adrenoreceptor agonist | 0.026 0.006 DBMET02635 0.02 0.011 DBMET02636 | DBMET02635 | |
| 0.045 | 0.061 | 0.055 | Thromboxane synthase inhibitor | 0.055 0.036 DBMET02635 | DBMET02635 | |
| 0.036 | 0.052 | 0.056 | Dopamine transporter inhibitor | 0.056 0.028 DBMET02635 | DBMET02635 | |
| 0.064 | 0.082 | 0.173 | Protein kinase A inhibitor | 0.105 0.042 DBMET02635 0.173 0.019 DBMET02636 | DBMET02636 | |
| 0.035 | 0.054 | 0.045 | AMPA receptor antagonist | 0.045 0.037 DBMET02636 | DBMET02636 | |
| 0.059 | 0.08 | 0.073 | Phospholipase D inhibitor | 0.073 0.046 DBMET02635 | DBMET02635 | |
| 0.027 | 0.048 | 0.05 | Glutamate (mGluR3) antagonist | 0.05 0.013 DBMET02636 | DBMET02636 | |
| 0.082 | 0.103 | 0.163 | 5 Hydroxytryptamine 3A agonist | 0.105 0.07 DBMET02635 0.163 0.029 DBMET02636 | DBMET02636 | |
| 0.056 | 0.077 | 0.088 | Aminopeptidase I inhibitor | 0.07 0.054 DBMET02635 0.088 0.035 DBMET02636 | DBMET02636 | |
| 0.011 | 0.033 | 0.015 | Nicotinic alpha4 receptor agonist | 0.015 0.013 DBMET02635 | DBMET02635 | |
| 0.048 | 0.072 | 0.077 | Phosphofructokinase-1 inhibitor | 0.077 0.043 DBMET02636 | DBMET02636 | |
| 0.015 | 0.041 | 0.02 | Toll-Like receptor 8 agonist | 0.02 0.015 DBMET02636 | DBMET02636 | |
| 0.021 | 0.047 | 0.035 | Purinergic P2Y15 antagonist | 0.029 0.019 DBMET02635 0.035 0.01 DBMET02636 | DBMET02636 | |
| 0.041 | 0.069 | 0.052 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.052 0.045 DBMET02636 | DBMET02636 | |
| 0.091 | 0.12 | 0.112 | Interleukin 8 antagonist | 0.112 0.073 DBMET02635 0.109 0.077 DBMET02636 | DBMET02635 | |
| 0.04 | 0.069 | 0.05 | Alpha-mannosidase inhibitor | 0.05 0.045 DBMET02635 0.05 0.045 DBMET02636 | DBMET02636 | |
| 0.052 | 0.083 | 0.07 | Histone deacetylase SIRT3 inhibitor | 0.07 0.029 DBMET02635 0.07 0.028 DBMET02636 | DBMET02636 | |
| 0.047 | 0.08 | 0.056 | Immunoglobulin Fc receptor antagonist | 0.056 0.034 DBMET02635 0.052 0.049 DBMET02636 | DBMET02635 | |
| 0.071 | 0.104 | 0.082 | Granulocyte macrophage colony stimulating factor agonist | 0.082 0.069 DBMET02636 | DBMET02636 | |
| 0.037 | 0.07 | 0.056 | Glutamate (mGluR1) antagonist | 0.056 0.043 DBMET02636 | DBMET02636 | |
| 0.015 | 0.048 | 0.025 | Melanocortin 5 antagonist | 0.025 0.018 DBMET02636 | DBMET02636 | |
| 0.024 | 0.058 | 0.046 | Alpha 1d adrenoreceptor agonist | 0.046 0.02 DBMET02635 0.044 0.021 DBMET02636 | DBMET02635 | |
| 0.017 | 0.051 | 0.026 | Glutamate (mGluR1) agonist | 0.023 0.022 DBMET02635 0.026 0.015 DBMET02636 | DBMET02636 | |
| 0.097 | 0.131 | 0.259 | Peroxidase inhibitor | 0.259 0.046 DBMET02636 | DBMET02636 | |
| 0.025 | 0.059 | 0.04 | Glutamate (mGluR4) agonist | 0.04 0.015 DBMET02636 | DBMET02636 | |
| 0.026 | 0.061 | 0.035 | Somatostatin 4 agonist | 0.035 0.028 DBMET02636 | DBMET02636 | |
| 0.074 | 0.11 | 0.108 | Nitric-oxide synthase inhibitor | 0.108 0.048 DBMET02635 0.107 0.049 DBMET02636 | DBMET02635 | |
| 0.029 | 0.066 | 0.064 | Glutamate (mGluR group III) agonist | 0.053 0.022 DBMET02635 0.064 0.017 DBMET02636 | DBMET02636 | |
| 0.038 | 0.075 | 0.06 | Lysine-specific demethylase 1A inhibitor | 0.06 0.028 DBMET02636 | DBMET02636 | |
| 0.167 | 0.207 | 0.219 | Tyrosine 3 hydroxylase inhibitor | 0.219 0.104 DBMET02636 | DBMET02636 | |
| 0.079 | 0.119 | 0.125 | Glutamate (mGluR7) agonist | 0.125 0.026 DBMET02635 0.093 0.076 DBMET02636 | DBMET02635 | |
| 0.019 | 0.06 | 0.05 | Complement C3a chemotactic receptor antagonist | 0.05 0.027 DBMET02636 | DBMET02636 | |
| 0.044 | 0.088 | 0.112 | Phenylalanine 4-hydroxylase inhibitor | 0.075 0.041 DBMET02635 0.112 0.021 DBMET02636 | DBMET02636 | |
| 0.114 | 0.16 | 0.14 | Tumour necrosis factor antagonist | 0.14 0.114 DBMET02636 | DBMET02636 | |
| 0.036 | 0.083 | 0.057 | Alpha 1 adrenoreceptor agonist | 0.057 0.04 DBMET02635 | DBMET02635 | |
| 0.027 | 0.075 | 0.044 | Mannosidase inhibitor | 0.044 0.033 DBMET02636 | DBMET02636 | |
| 0.072 | 0.121 | 0.09 | Electrolyte absorption antagonist | 0.09 0.074 DBMET02636 | DBMET02636 | |
| 0.169 | 0.221 | 0.209 | Antithrombotic | 0.209 0.166 DBMET02636 | DBMET02636 | |
| 0.148 | 0.2 | 0.275 | Peptidyltransferase inhibitor | 0.262 0.043 DBMET02635 0.275 0.035 DBMET02636 | DBMET02636 | |
| 0.032 | 0.083 | 0.051 | Glutamate (mGluR group III) antagonist | 0.051 0.02 DBMET02636 | DBMET02636 | |
| 0.017 | 0.07 | 0.039 | Phosphoglycerate kinase inhibitor | 0.039 0.02 DBMET02636 | DBMET02636 | |
| 0.071 | 0.124 | 0.159 | GABA C receptor rho-1 antagonist | 0.111 0.049 DBMET02635 0.159 0.018 DBMET02636 | DBMET02636 | |
| 0.008 | 0.063 | 0.023 | Growth hormone releasing factor antagonist | 0.023 0.017 DBMET02636 | DBMET02636 | |
| 0.046 | 0.102 | 0.063 | CXC chemokine receptor antagonist | 0.063 0.061 DBMET02636 | DBMET02636 | |
| 0.058 | 0.115 | 0.157 | Aminopeptidase B inhibitor | 0.157 0.035 DBMET02636 | DBMET02636 | |
| 0.047 | 0.106 | 0.073 | Epoxide hydrolase inhibitor | 0.073 0.05 DBMET02635 | DBMET02635 | |
| 0.049 | 0.108 | 0.095 | Glutamate dehydrogenase inhibitor | 0.095 0.033 DBMET02636 | DBMET02636 | |
| 0.009 | 0.069 | 0.036 | CXC chemokine receptor agonist | 0.036 0.021 DBMET02636 | DBMET02636 | |
| 0.019 | 0.085 | 0.044 | Tryptase inhibitor | 0.044 0.017 DBMET02636 | DBMET02636 | |
| 0.032 | 0.099 | 0.051 | Myc inhibitor | 0.051 0.042 DBMET02635 | DBMET02635 | |
| 0.052 | 0.121 | 0.109 | NMDA receptor antagonist | 0.109 0.042 DBMET02636 | DBMET02636 | |
| 0.06 | 0.132 | 0.09 | Creatine kinase inhibitor | 0.09 0.071 DBMET02636 | DBMET02636 | |
| 0.109 | 0.182 | 0.16 | I kappa B kinase epsilon inhibitor | 0.16 0.109 DBMET02635 | DBMET02635 | |
| 0.028 | 0.102 | 0.096 | Alcohol oxidase inhibitor | 0.096 0.019 DBMET02636 | DBMET02636 | |
| 0.011 | 0.086 | 0.027 | Lysine carboxypeptidase inhibitor | 0.027 0.018 DBMET02636 | DBMET02636 | |
| 0.011 | 0.087 | 0.028 | Somatostatin 4 antagonist | 0.028 0.013 DBMET02636 | DBMET02636 | |
| 0.033 | 0.11 | 0.077 | Toll-Like receptor 7 antagonist | 0.077 0.04 DBMET02635 | DBMET02635 | |
| 0.016 | 0.096 | 0.027 | Thrombin receptor antagonist | 0.027 0.021 DBMET02636 | DBMET02636 | |
| 0.126 | 0.206 | 0.155 | Growth factor agonist | 0.155 0.13 DBMET02635 | DBMET02635 | |
| 0.016 | 0.098 | 0.064 | Somatostatin 1 antagonist | 0.064 0.014 DBMET02636 | DBMET02636 | |
| 0.047 | 0.132 | 0.06 | Transcription factor RelA inhibitor | 0.06 0.054 DBMET02636 | DBMET02636 | |
| 0.027 | 0.116 | 0.048 | Glutamate (mGluR4) antagonist | 0.048 0.023 DBMET02636 | DBMET02636 | |
| 0.015 | 0.104 | 0.042 | Vascular adhesion protein 1 inhibitor | 0.042 0.023 DBMET02636 | DBMET02636 | |
| 0.019 | 0.109 | 0.033 | Carboxypeptidase B inhibitor | 0.033 0.023 DBMET02636 | DBMET02636 | |
| 0.022 | 0.116 | 0.038 | Neurokinin 2 agonist | 0.038 0.034 DBMET02636 | DBMET02636 | |
| 0.142 | 0.236 | 0.192 | Gastrin inhibitor | 0.192 0.162 DBMET02635 | DBMET02635 | |
| 0.027 | 0.127 | 0.047 | Baculoviral IAP repeat-containing protein inhibitor | 0.047 0.029 DBMET02635 | DBMET02635 | |
| 0.007 | 0.109 | 0.048 | Somatostatin 2 antagonist | 0.048 0.016 DBMET02636 | DBMET02636 | |
| 0.063 | 0.169 | 0.096 | Carbonic anhydrase XV inhibitor | 0.096 0.073 DBMET02636 | DBMET02636 | |
| 0.05 | 0.162 | 0.097 | HIV-1 integrase (Overall Integration) inhibitor | 0.097 0.058 DBMET02636 | DBMET02636 | |
| 0.016 | 0.128 | 0.037 | Dopamine D5 agonist | 0.037 0.033 DBMET02636 | DBMET02636 | |
| 0.01 | 0.125 | 0.04 | Kinesin antagonist | 0.04 0.022 DBMET02636 | DBMET02636 | |
| 0.01 | 0.125 | 0.04 | Kinesin-like protein 1 inhibitor | 0.04 0.022 DBMET02636 | DBMET02636 | |
| 0.047 | 0.162 | 0.085 | Inducible nitric-oxide synthase inhibitor | 0.085 0.055 DBMET02635 0.085 0.054 DBMET02636 | DBMET02636 | |
| 0.033 | 0.153 | 0.098 | Glutamate decarboxylase inhibitor | 0.098 0.031 DBMET02636 | DBMET02636 | |
| 0.028 | 0.148 | 0.064 | Carbonic anhydrase stimulant | 0.064 0.036 DBMET02635 0.061 0.039 DBMET02636 | DBMET02635 | |
| 0.007 | 0.131 | 0.019 | Somatostatin 3 antagonist | 0.019 0.015 DBMET02636 | DBMET02636 | |
| 0.03 | 0.155 | 0.064 | Bombesin 1 receptor agonist | 0.064 0.037 DBMET02635 | DBMET02635 | |
| 0.035 | 0.162 | 0.078 | Thrombin inhibitor | 0.078 0.044 DBMET02636 | DBMET02636 | |
| 0.015 | 0.145 | 0.057 | Ornithine carbamoyltransferase inhibitor | 0.057 0.033 DBMET02636 | DBMET02636 | |
| 0.043 | 0.175 | 0.064 | Glutamate (mGluR6) antagonist | 0.064 0.054 DBMET02636 | DBMET02636 | |
| 0.038 | 0.174 | 0.102 | Ornithine decarboxylase inhibitor | 0.102 0.042 DBMET02636 | DBMET02636 | |
| 0.07 | 0.221 | 0.119 | Protein kinase stimulant | 0.119 0.094 DBMET02636 | DBMET02636 | |
| 0.047 | 0.199 | 0.082 | GABA B receptor agonist | 0.082 0.038 DBMET02636 | DBMET02636 | |
| 0.035 | 0.188 | 0.073 | GABA aminotransferase inhibitor | 0.073 0.056 DBMET02636 | DBMET02636 | |
| 0.025 | 0.179 | 0.074 | Glutamate receptor agonist | 0.074 0.059 DBMET02636 | DBMET02636 | |
| 0.056 | 0.209 | 0.129 | Nav1.4 sodium channel blocker | 0.129 0.045 DBMET02636 | DBMET02636 | |
| 0.063 | 0.217 | 0.104 | Cathepsin H inhibitor | 0.104 0.1 DBMET02636 | DBMET02636 | |
| 0.104 | 0.267 | 0.159 | Neurotensin receptor agonist | 0.159 0.082 DBMET02636 | DBMET02636 | |
| 0.035 | 0.2 | 0.124 | Somatostatin 1 agonist | 0.124 0.022 DBMET02636 | DBMET02636 | |
| 0.022 | 0.192 | 0.046 | GABA B receptor antagonist | 0.046 0.025 DBMET02636 | DBMET02636 | |
| 0.036 | 0.229 | 0.059 | Trypsin inhibitor | 0.059 0.05 DBMET02636 | DBMET02636 | |
| 0.021 | 0.224 | 0.079 | Histidine decarboxylase inhibitor | 0.079 0.043 DBMET02636 | DBMET02636 | |
| 0.035 | 0.249 | 0.068 | Glycine receptor agonist | 0.068 0.059 DBMET02636 | DBMET02636 | |
| 0.027 | 0.249 | 0.047 | Alpha 1b adrenoreceptor agonist | 0.047 0.043 DBMET02635 | DBMET02635 | |
| 0.035 | 0.266 | 0.079 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.079 0.065 DBMET02636 | DBMET02636 | |
| 0.004 | 0.271 | 0.04 | Somatostatin 5 antagonist | 0.04 0.018 DBMET02636 | DBMET02636 | |
| 0.022 | 0.316 | 0.124 | Protein kinase B gamma inhibitor | 0.124 0.024 DBMET02636 | DBMET02636 | |
| 0.011 | 0.308 | 0.042 | Growth hormone release inhibitor | 0.042 0.029 DBMET02636 | DBMET02636 | |
| 0.135 | 0.443 | 0.516 | Calcium channel L-type activator | 0.516 0.022 DBMET02635 | DBMET02635 | |
| 0.031 | 0.356 | 0.145 | Thrombolytic | 0.145 0.085 DBMET02636 | DBMET02636 | |
| 0.041 | 0.396 | 0.184 | Interleukin antagonist | 0.184 0.093 DBMET02636 | DBMET02636 | |
| 0.067 | 0.468 | 0.182 | Death-associated protein kinase 2 inhibitor | 0.182 0.051 DBMET02636 | DBMET02636 | |
| 0.009 | 0.502 | 0.043 | Somatostatin 5 agonist | 0.043 0.016 DBMET02636 | DBMET02636 | |
| 0.037 | 0.724 | 0.196 | Growth hormone agonist | 0.196 0.06 DBMET02636 | DBMET02636 | |
| 0.054 | 0.793 | 0.266 | Interleukin 2 agonist | 0.266 0.102 DBMET02636 | DBMET02636 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |